斯塔林肿瘤 STLN
$3.62 −$3.08 (-45.97%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $3.63 +0.28%
开盘$6.06
昨收$6.70
当日区间$3.35 – $6.43
成交量23.92M
市值$369.21M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$161.28M+34.6% YoY
营业利润-$4.62M+58.8% YoY
净利润-$9.79M+42.4% YoY
摊薄每股收益-$0.08+46.7% YoY
自由现金流$11.03M+196.7% YoY
经营现金流$11.94M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率15.7%
营业利润率-4.4%
净利率-5.2%
资产收益率-18.1%
流动比率1.36
负债/资产比率114.0%
现金及投资$41.09M
总负债$97.25M
净现金（净负债）-$56.16M
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $161.28M | $147.44M | $502.73M | $141.96M | $136.56M |
| 营业总收入 | $161.28M | $147.44M | $502.73M | $141.96M | $136.56M |
| 营业成本 | $134.12M | $124.13M | $426.29M | $119.19M | $117.64M |
| 毛利润 | $27.17M | $23.32M | $76.44M | $22.77M | $18.92M |
| 营业费用 | $31.78M | $29.83M | $112.52M | $29.67M | $26.97M |
| 销售及管理费用 | $29.94M | $28.21M | $105.57M | $28.04M | $25.25M |
| 折旧、摊销与折耗 | $1.84M | $1.62M | $6.94M | $1.63M | $1.72M |
| -折旧与摊销 | $1.84M | $1.62M | $6.94M | $1.63M | $1.72M |
| 营业利润 | -$4.62M | -$6.51M | -$36.08M | -$6.91M | -$8.05M |
| 非经营性利息净收入（支出） | -$1.86M | -$1.93M | -$11.28M | -$1.92M | -$1.92M |
| 非经营性利息支出 | $1.86M | $1.93M | $11.28M | $1.92M | $1.92M |
| 其他收入（支出） | -$3.31M | $5.96M | -$13.38M | $1.32M | -$6.53M |
| 证券出售收益 | -$3.24M | $5.16M | -$12.45M | $1.07M | -$6.13M |
| 其他非经营性收入（支出） | -$77,000.00 | $791,000.00 | -$925,000.00 | $249,000.00 | -$403,000.00 |
| 税前利润 | -$9.79M | -$2.49M | -$60.74M | -$7.51M | -$16.50M |
| 税费 | $0.00 | $0.00 | -$131,000.00 | $0.00 | $0.00 |
| 净利润 | -$9.79M | -$2.49M | -$60.61M | -$7.51M | -$16.50M |
| 持续经营利润 | -$9.79M | -$2.49M | -$60.61M | -$7.51M | -$16.50M |
| 归属母公司净利润 | -$9.79M | -$2.49M | -$60.61M | -$7.51M | -$16.50M |
| 其他优先股股息 | -$1.55M | -$398,000.00 | -$10.30M | -$1.08M | -$2.73M |
| 归属普通股股东净利润 | -$8.24M | -$2.09M | -$50.31M | -$6.43M | -$13.77M |
| 基本每股收益 | -$0.08 | -$0.02 | -$0.54 | -$0.06 | -$0.14 |
| 摊薄每股收益 | -$0.08 | -$0.02 | -$0.54 | -$0.06 | -$0.14 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $178.23M | $168.23M | $164.66M | $164.66M | $163.62M |
| 流动资产合计 | $128.99M | $116.86M | $112.75M | $112.75M | $110.09M |
| 现金及现金等价物与短期投资 | $41.09M | $30.28M | $33.57M | $33.57M | $27.66M |
| -现金及现金等价物 | $41.09M | $30.28M | $33.57M | $33.57M | $27.66M |
| 应收款 | $66.71M | $59.45M | $59.32M | $59.32M | $59.98M |
| -应收账款 | $66.35M | $58.13M | $59.00M | $59.00M | $59.64M |
| -其他应收款 | $360,000.00 | $1.32M | $322,000.00 | $322,000.00 | $300,000.00 |
| 存货 | $20.01M | $24.29M | $16.88M | $16.88M | $18.88M |
| 其他流动资产 | $1.18M | $2.84M | $2.99M | $2.99M | $3.57M |
| 非流动资产合计 | $49.24M | $51.37M | $51.91M | $51.91M | $53.53M |
| 固定资产净值 | $31.77M | $33.22M | $33.06M | $33.06M | $33.98M |
| -固定资产原值 | $44.64M | $45.04M | $43.98M | $43.98M | $43.99M |
| -累计折旧 | -$12.86M | -$11.83M | -$10.93M | -$10.93M | -$10.01M |
| 商誉及其他无形资产 | $16.82M | $17.53M | $18.25M | $18.25M | $18.96M |
| -商誉 | $7.23M | $7.23M | $7.23M | $7.23M | $7.23M |
| -其他无形资产 | $9.59M | $10.30M | $11.02M | $11.02M | $11.73M |
| 其他非流动资产 | $657,000.00 | $620,000.00 | $606,000.00 | $606,000.00 | $586,000.00 |
| 负债合计 | $203.15M | $184.52M | $180.38M | $180.38M | $175.89M |
| 流动负债合计 | $94.94M | $79.35M | $70.96M | $70.96M | $65.58M |
| 应付款 | $60.28M | $47.65M | $43.17M | $43.17M | $35.63M |
| -应付账款 | $60.28M | $47.65M | $43.17M | $43.17M | $35.63M |
| 一年内应计费用 | $13.08M | $9.78M | $5.20M | $5.20M | $2.74M |
| 短期债务及融资租赁负债 | $7.23M | $7.40M | $7.16M | $7.16M | $7.16M |
| -一年内到期融资租赁负债 | $7.23M | $7.40M | $7.16M | $7.16M | $7.16M |
| 一年内递延负债 | $2.50M | $3.05M | $4.04M | $4.04M | $7.34M |
| 其他流动负债 | $6.24M | $5.67M | $4.31M | $4.31M | $4.71M |
| 非流动负债合计 | $108.21M | $105.16M | $109.41M | $109.41M | $110.31M |
| 长期债务及融资租赁负债 | $97.25M | $97.45M | $96.53M | $96.53M | $96.39M |
| -长期债务 | $79.87M | $78.61M | $77.40M | $77.40M | $76.20M |
| -长期融资租赁负债 | $17.38M | $18.84M | $19.13M | $19.13M | $20.20M |
| 衍生产品负债 | $10.93M | $7.69M | $12.86M | $12.86M | $13.92M |
| 其他非流动负债 | $30,000.00 | $19,000.00 | $28,000.00 | $28,000.00 | $3,000.00 |
| 股东权益合计 | -$24.91M | -$16.29M | -$15.72M | -$15.72M | -$12.27M |
| 股东权益 | -$24.91M | -$16.29M | -$15.72M | -$15.72M | -$12.27M |
| 股本 | $10,000.00 | $10,000.00 | $10,000.00 | $10,000.00 | $10,000.00 |
| -普通股 | $10,000.00 | $10,000.00 | $10,000.00 | $10,000.00 | $10,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $259.80M | $258.64M | $256.71M | $256.71M | $252.65M |
| 留存收益 | -$283.70M | -$273.91M | -$271.42M | -$271.42M | -$263.91M |
| 减：库存股 | $1.02M | $1.02M | $1.02M | $1.02M | $1.02M |
| 一年以上递延负债 | – | – | $0.00 | $0.00 | $0.00 |
| -应计应收利息 | – | – | – | – | $39,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $11.94M | -$2.22M | -$24.59M | $3.23M | -$12.63M |
| 持续经营经营活动现金流净额 | $11.94M | -$2.22M | -$24.59M | $3.23M | -$12.63M |
| 持续经营净利润 | -$9.79M | -$2.49M | -$60.61M | -$7.51M | -$16.50M |
| 持续经营损益 | $3.44M | -$5.16M | $14.85M | -$1.07M | $6.22M |
| 折旧、折耗与摊销 | $1.84M | $1.62M | $6.94M | $1.63M | $1.72M |
| 其他非现金项目 | $1.08M | $1.21M | $8.38M | $1.21M | $1.08M |
| 营运资金变动 | $14.30M | $928,000.00 | $1.33M | $7.65M | -$6.17M |
| -应收款变动 | -$7.26M | -$130,000.00 | -$12.58M | $658,000.00 | -$4.04M |
| -存货变动 | $4.28M | -$7.42M | -$6.84M | $2.01M | -$3.10M |
| -预付资产变动 | $1.67M | $144,000.00 | $2.03M | $230,000.00 | $553,000.00 |
| -应付账款及应计费用变动 | $15.94M | $8.53M | $19.19M | $4.87M | $566,000.00 |
| -其他流动资产变动 | -$37,000.00 | -$14,000.00 | -$17,000.00 | -$20,000.00 | $0.00 |
| -其他流动负债变动 | -$472,000.00 | $0.00 | -$11,000.00 | $84,000.00 | $122,000.00 |
| 投资活动现金流净额 | -$908,000.00 | -$1.04M | -$3.07M | -$1.06M | -$604,000.00 |
| 持续经营投资活动现金流净额 | -$908,000.00 | -$1.04M | -$3.07M | -$1.06M | -$604,000.00 |
| 固定资产购置及出售净额 | -$908,000.00 | -$1.04M | -$3.20M | -$1.06M | -$604,000.00 |
| 筹资活动现金流 | -$218,000.00 | -$28,000.00 | $11.56M | $3.73M | $10.60M |
| 持续经营筹资活动现金流净额 | -$218,000.00 | -$28,000.00 | $11.56M | $3.73M | $10.60M |
| 债务发行及偿还净额 | -$8,000.00 | -$9,000.00 | -$20.04M | -$9,000.00 | -$8,000.00 |
| 普通股发行净额 | $0.00 | $0.00 | $29.20M | $3.89M | $9.95M |
| 股票期权行使所得 | $90,000.00 | $241,000.00 | $3.44M | $204,000.00 | $891,000.00 |
| 其他筹资费用净额 | -$300,000.00 | -$260,000.00 | -$1.04M | -$350,000.00 | -$235,000.00 |
| 期末现金余额 | $41.09M | $30.28M | $33.57M | $33.57M | $27.66M |
| 现金净变动 | $10.81M | -$3.29M | -$16.10M | $5.91M | -$2.63M |
| 期初现金余额 | $30.28M | $33.57M | $49.67M | $27.66M | $30.29M |
| 自由现金流 | $11.03M | -$3.26M | -$27.79M | $2.17M | -$13.23M |
| -其他营运资金变动 | – | -$186,000.00 | -$452,000.00 | -$178,000.00 | – |
| 递延税款 | – | – | -$32,000.00 | $0.00 | $0.00 |
| 投资购置及出售净额 | – | – | $0.00 | $0.00 | – |
| 其他投资变动净额 | – | – | $126,000.00 | $0.00 | $0.00 |
暂无评论——快来第一个聊聊 STLN。
登录后参与讨论。